<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>199(2)</volume><submitter>Kim HR</submitter><funding>NCI NIH HHS</funding><journal>American journal of respiratory and critical care medicine</journal><pagination>243-246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6835091</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Ratio of Peripheral Regulatory T Cells to Lox-1&lt;sup>+&lt;/sup> Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.</pubmed_title><pmcid>PMC6835091</pmcid><funding_grant_id>P30 CA010815</funding_grant_id><pubmed_authors>Park SM</pubmed_authors><pubmed_authors>Seo SU</pubmed_authors><pubmed_authors>Cho BC</pubmed_authors><pubmed_authors>Jung I</pubmed_authors><pubmed_authors>Youn JI</pubmed_authors><pubmed_authors>Gabrilovich DI</pubmed_authors><pubmed_authors>Ha SJ</pubmed_authors><pubmed_authors>Kim HR</pubmed_authors><pubmed_authors>Seong SY</pubmed_authors><pubmed_authors>Yoon HI</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Ratio of Peripheral Regulatory T Cells to Lox-1&lt;sup>+&lt;/sup> Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2026-05-07T07:31:10.427Z</modification><creation>2026-04-07T22:44:34.374Z</creation></dates><accession>S-EPMC6835091</accession><cross_references><pubmed>30339766</pubmed><doi>10.1164/rccm.201808-1502LE</doi><doi>10.1164/rccm.201808-1502le</doi></cross_references></HashMap>